Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)
Clinical trial NCT03830866 · COMPLETED
Trial details
- NCT number
- NCT03830866
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2022-01-20
- Enrollment
- 770
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.